Recon: J&J forecasts $2.5B in 2021 COVID vaccine sales; South Af...
07/21/21
Recon: J&J forecasts $2.5B in 2021 COVID vaccine sales; South Africa's Biovac to make Pfizer-BioNTech vaccine in 2022 Regulatory Focus
[more]- Feeds Categories: